Holen Sie sich die Stockscreener-App
2.11
6.64%
-0.15
Handel nachbörslich:
2.09
-0.02
-0.95%
Lunai Bioworks Inc Aktie (LNAI) Neueste Nachrichten
Lunai Bioworks, Inc. Financial Disclosures & SEC Filings - TradingView
Lunai Bioworks Heads Into Key Week After Reverse Split, Ongoing Court Battle - Bez Kabli
Lunai Bioworks to implement 1-for-8 reverse stock split - MSN
Lunai Bioworks Inc. (LNAI) Q1 2026 Earnings: Pre-Revenue Biotech Reports Wider-Than-Expected Loss Amid Pipeline ProgressEnergy Earnings Report - Newser
Lunai Bioworks federal judge grants Lunai Bioworks expedited discovery to identify "naked" short sellers - marketscreener.com
Lunai Bioworks Federal Judge Grants Lunai Bioworks Expedited Discovery To Identify "Naked" Short Sellers - TradingView
Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock - PR Newswire
Lunai Bioworks Inc. (LNAI) Q1 2026 Earnings: Early-Stage Biotech Delivers Strategic Progress Despite GAAP LossTrending Volume Leaders - Newser
LNAI Should I Buy - Intellectia AI
Lunai Bioworks (LNAI) Q1 2026 Earnings: As Expected, No SurprisesEarnings Volatility Report - Newser
Lunai Bioworks Announces 1-for-8 Reverse Stock Split - The Globe and Mail
Lunai Bioworks Announces 1-for-8 Reverse Stock Split to Regain Nasdaq Compliance - Minichart
Lunai Bioworks stock falls after reverse split announcement By Investing.com - Investing.com South Africa
Lunai Bioworks announces 1-for-8 reverse stock split By Investing.com - Investing.com Australia
Lunai Bioworks announces 1-for-8 reverse stock split - Investing.com
Lunai Bioworks, Inc. Announces Reverse Stock Split - TradingView
Lunai Bioworks stock falls after reverse split announcement - Investing.com
Lunai Bioworks announces 1-for-8 reverse stock split to boost Nasdaq compliance, shares cut to ~4.53M - TradingView
Lunai Bioworks (NASDAQ: LNAI) plans 1-for-8 reverse split to meet Nasdaq price rule - Stock Titan
LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT - PR Newswire
Dickinson Wright And Fox Rothschild Join Forces To File Lawsuit Against ‘John Doe’ ‘Naked’ Short-Sellers Of Lunai Common Stock - marketscreener.com
LNAI Stock Chart | LUNAI BIOWORKS INC (NASDAQ:LNAI) - ChartMill
Lunai Bioworks: Fiscal Q3 Earnings Snapshot - 10TV
Lunai Bioworks Inc. 3Q 2026: Revenue $20942 Net loss $(2.57M), EPS $(0.10) — 10-Q Summary - TradingView
[10-Q] Lunai Bioworks Inc. Quarterly Earnings Report - Stock Titan
Lunai Bioworks Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 - marketscreener.com
Lunai Bioworks Shareholders Approve Flexible Reverse Stock Split - The Globe and Mail
Lunai Bioworks Inc approves reverse stock split at ratio of 1-for-3 to 1-for-30SEC filing - marketscreener.com
Lunai Bioworks IncApproves Reverse Stock Split At Ratio Of 1-For-3 To 1-For-30SEC Filing - TradingView
Lunai Bioworks shareholders approve reverse stock split and meeting adjournment By Investing.com - Investing.com South Africa
Lunai Bioworks shareholders approve reverse stock split and meeting adjournment - Investing.com Nigeria
Lunai Bioworks (NASDAQ: LNAI) wins shareholder approval for reverse stock split - Stock Titan
Lunai Bioworks Files Securities Fraud Lawsuit Alleging Naked Short Selling Scheme - citybuzz -
Dickinson Wright and Fox Rothschild Join Forces to File Lawsuit Against ‘John Doe’ ‘Naked’ Short-Sellers of Lunai Common Stock - The Manila Times
Dickinson Wright and Fox Rothschild Join Forces to File Lawsuit Against ‘John Doe’ ‘Naked’ Short-Sellers of Lunai Common Stock - GlobeNewswire Inc.
Lunai Bioworks (LNAI) warns of Nasdaq delisting risk after MVLS shortfall - Stock Titan
How Lunai Bioworks (LNAI) performance reflects its true potential (-0.90%) 2026-05-10Continuation Signals - newser.com
Why Lunai Bioworks (LNAI) might be the best kept secret in the market (At Lows) 2026-05-08Expert Momentum Signals - newser.com
Number of shareholders of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
LNAI: Shareholders voted on a reverse stock split and adjournment proposal, both board-recommended - TradingView
The key trends fueling Lunai Bioworks (LNAI) growth potential (+6.29%) 2026-05-08Micro Trends - newser.com
Oncotelic Therapeutics Announces Closing of a Strategic - GlobeNewswire
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease - Yahoo Finance
Stock Market Today: Nasdaq, S&P 500 Futures Gain While Dow Slips Amid Israel-Lebanon Ceasefire Extension—Intel, SAP, Lunai Bioworks In Focus (UPDATED) - MSN
Oncotelic Therapeutics Completes Neurobridge IP Merger With Lunai Bioworks for $20M in Preferred Stock - TradingView
Lunai Bioworks Stock: $20 Million Patent Deal Puts Nasdaq Fight in Focus - TechStock²
Lunai Bioworks Completes $20 Million Preferred Equity Issuance - Intellectia AI
A $20M Lunai deal adds two routes past the blood-brain barrier - Stock Titan
Lunai Bioworks Inc. completed the acquisition of BBB delivery technology and CNS Alzheimer's drug assets of Clemann Group from Clemann Group. - marketscreener.com
Lunai Bioworks initiates employee furloughs and salary deferrals to preserve liquidity - Investing.com
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):